Wird geladen...
Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
OBJECTIVE: It is unknown whether there are differences in efficacy and safety between quetiapine extended‐release, 300 mg/d (QUEXR300), and olanzapine, 5‐20 mg/d (OLA), for Japanese patients with bipolar depression. METHODS: We conducted a Bayesian analysis of data from phase 3 studies in Japan of Q...
Gespeichert in:
| Veröffentlicht in: | Neuropsychopharmacol Rep |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292317/ https://ncbi.nlm.nih.gov/pubmed/31283865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/npr2.12070 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|